Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience. [PDF]
Hendrikx B +9 more
europepmc +1 more source
Longitudinal Radiological Remodeling after Irreversible Electroporation Versus Radiofrequency Ablation: A Prospective Comparative Study (The LIRA Study). [PDF]
Liu Y +11 more
europepmc +1 more source
Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study. [PDF]
Xi P +6 more
europepmc +1 more source
Spatial multiomics reveals irreversible electroporation-induced immuno-metabolic characteristics of the inflammatory margin in liver cancer. [PDF]
Liu J +7 more
europepmc +1 more source
Multiparametric MRI to Predict Response to Irreversible Electroporation Plus Anti-PD-1 Immunotherapy in Pancreatic Ductal Adenocarcinoma. [PDF]
Cao Q +9 more
europepmc +1 more source
Pancreatic Tissue Remodeling and Fibrosis After Irreversible Electroporation: A Histopathological and Thermal Perspective. [PDF]
Kim HB, Youm JY, Yang JM, Sim SB.
europepmc +1 more source
Impact of Voltage on the Production on Spherical Ablations for Integrated Time Nanosecond Pulse Irreversible Electroporation. [PDF]
Williamson RH +7 more
europepmc +1 more source
Hypertension and tachycardia induced by irreversible electroporation in pancreatic cancer: An analysis based on clinical data. [PDF]
Li HM +5 more
europepmc +1 more source
Erratum: Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model. [PDF]
Figini M +13 more
europepmc +1 more source
High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): a single-centre, randomised, double-blind, phase 3, non-inferiority trial. [PDF]
He BM +9 more
europepmc +1 more source

